General Information of the Compound
Compound ID
CP0520194
Compound Name
3-[[5-[3-fluoro-2-(trifluoromethyl)phenyl]tetrazol-1-yl]methyl]pyridine
    Show/Hide
Structure
Formula
C14H9F4N5
Molecular Weight
323.253
Canonical SMILES
Fc1cccc(-c2nnnn2Cc2cccnc2)c1C(F)(F)F
    Show/Hide
InChI
InChI=1S/C14H9F4N5/c15-11-5-1-4-10(12(11)14(16,17)18)13-20-21-22-23(13)8-9-3-2-6-19-7-9/h1-7H,8H2
    Show/Hide
InChIKey
JAFJCMSLIIJZDD-UHFFFAOYSA-N
Physicochemical Property
logP
2.9413
Rotatable Bonds
3
Heavy Atom Count
23
Polar Areas
56.49
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11688382
SID: 16792708
ChEMBL ID
CHEMBL206904
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 630.96 nM
   TI
   LI
   LO
   TS